FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091225 [Registered on: 21/07/2025] Trial Registered Prospectively
Last Modified On: 18/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Developing a model for cardiac rehabilitation: an experimental study 
Scientific Title of Study   Developing a model for delivery of long-term cardiac rehabilitation: an experimental study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Bhalchandra Shahadeorao Kharsade PT 
Designation  Associate Professor 
Affiliation  MGM SCHOOL OF PHYSIOTHERAPY, MGMIHS 
Address  MGM School of Physiotherapy, Department Musculoskeletal Sciences, Room No.1, MGM Campus, N-6 Cidco, Chhatrapati Sambhajinagar,431003

Aurangabad
MAHARASHTRA
431003
India 
Phone  7038111952  
Fax    
Email  drbhalchandrakharsade@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Bela Agrawal 
Designation  Professor & HOD 
Affiliation  MGM SCHOOL OF PHYSIOTHERAPY, MGMIHS, NAVI Mumbai 
Address  Department of cardio respiratory, physiotherapy, MGM School of Physiotherapy, MGM Institute of Health Sciences, Kamothe, Navi Mumbai 410209

Mumbai (Suburban)
MAHARASHTRA
410209
India 
Phone  9819000674  
Fax    
Email  bagarwal@mgmsopnm.edu.in   
 
Details of Contact Person
Public Query
 
Name  Dr Bela Agrawal 
Designation  Professor & HOD 
Affiliation  MGM SCHOOL OF PHYSIOTHERAPY, MGMIHS, NAVI Mumbai 
Address  Department of cardio respiratory, physiotherapy, MGM School of Physiotherapy, MGM Institute of Health Sciences, Kamothe, Navi Mumbai 410209

Mumbai (Suburban)
MAHARASHTRA
410209
India 
Phone  9819000674  
Fax    
Email  bagarwal@mgmsopnm.edu.in   
 
Source of Monetary or Material Support  
MGM School of Physiotherapy, N-6 CIDCO, Chhatrapati Sambhajinagar-431003 
 
Primary Sponsor  
Name  MGM Institute of Health Sciences 
Address  MGM Institute of Health Sciences, Kamothe, Navi Mumbai 410209 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Bhalchandra Kharsade  MGM Hospital, MGM School of Physiotherapy  MGM School of Physiotherapy, N-6 CIDCO, Chh.Sambhajinagar-431003.
Aurangabad
MAHARASHTRA 
7038111952

drbhalchandrakharsade@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethics committee for research on human subjects of MGM Institute of health sciences  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I20-I25||Ischemic heart diseases,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  cardiac rehabilitation at Primary health center  Weeks 1-2: Initial assessment by primary care professionals. A physiotherapist supervised low-impact activities such as walking or light stretching. Patient education on adherence to prescribed medications by doctors. Weeks 3-4: Gradually increase exercise intensity supervised at local health centers-peer group sessions for behavioral and emotional support. Weeks 5-6: Encouragement of self-led exercise programs with periodic check-ins. Transition to maintenance phase with focus on sustaining lifestyle changes. Progression over 6 to 12 Weeks: Individualized care and self-management Care: Weeks 6-8: Guidance through remote consultations. Simple exercises like walking around the house or stretching. Education materials (digital or printed) for self-guided learning  
Intervention  Cardiac rehabilitation for ischemic heart diseases Territory center  1.Patient Education 2.Aerobic Exercises: Structured Walking Program 150 MET min/week, 3.Muscle strengthening Exercises, Balance training 2 days per week. 4.Fitness training 5.Education and support for a healthy lifestyle 6.Education, advice, and Support for self- management of health conditions. 7.Career and family Training 8.Referral for Vocational counselling as per feasibility. 9.Health Education and support for a healthy lifestyle Smoking and alcohol consumption cessation 10.Education, advice, and support for self- management of health 12.Education of Career and family training.  
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  a.Males and females in the age group 40-70 years
b.Diagnosed with IHD, managed medically or surgically –PTCA/CABG, stable for at least 2
weeks.
c. Patients in phase II and phase III cardiac rehabilitation 
 
ExclusionCriteria 
Details  a.Any medical red flags
b.Acutely unstable patients with cardiovascular diseases
c.Acute infective pathology
d.Neurological condition
e. Non-cooperative patients
f. Unstable psychological condition
g. Who is not willing to participate in the study 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.Duke Activity Status Index,
2.Mental Health Quality of Life questionnaire (MHQoL),
3.SF 36 Questionnaire score,
4.Tampa Kinesiophobia Questionnaire score,
5.Global Physical Activity questionnaire score, 
at baseline 6 weeks, and 12 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
1. Hand grip
2. Blood pressure,
3. Heart rate,
4. SpO2,
5. Sit & Reach test distance
6. Sit-to-Stand test repetition,
7. Y balance test
8. Body Composition (BMI & waist-hip ratio),
9.6 Minute Walk test
 
at baseline 6 weeks,12 weeks 
 
Target Sample Size   Total Sample Size="225"
Sample Size from India="225" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Title of the study: Developing a Model for Delivery of Long-Term Cardiac Rehabilitation: An Experimental Study

Background and Rationale:

Research supports the benefits of CR, which shows that it enhances cardiovascular endurance, muscular strength, and mental health. Researching PHC-based CR could make rehabilitation more accessible to less fortunate groups. The relative benefits of tertiary care over PHC-based CR can impact healthcare policy and resource allocation. Effect over Time: Evaluating long-term outcomes ensures continued benefits and adherence to lifestyle changes. 

Cardiac rehabilitation is a key component in maintaining and improving outcomes for patients with ischemic heart disease. The effectiveness of various delivery modalities, including tertiary care hospital-based and primary health care-based, remains uncertain. Each technique may offer unique benefits and challenges in terms of increasing important health indices such as cardiovascular endurance, physical strength and mobility, cognitive functioning, mental well-being, and overall quality of life. The uncertainty around the comparative efficacy of various treatments makes it difficult for healthcare practitioners to establish optimal rehabilitation programs that are tailored to the needs of patients and available resources. Addressing this knowledge gap is crucial for improving patient care.

This research can prove that Cardiac rehabilitation (CR) is a critical component of long-term management for patients with ischemic heart disease (IHD), as it addresses both physical and mental well-being. However, traditional CR models delivered through tertiary care hospitals often face challenges related to accessibility, affordability, and convenience, particularly for patients in rural or resource-limited settings. Exploring and comparing alternative CR delivery models, such as primary health care-based and home-based CR, holds great clinical significance.

Aim: To develop a model of care for the delivery of long-term cardiac rehabilitation and to study the efficacy of PHC-based CR compared to tertiary care CR in terms of outcomes such as cardiovascular endurance, muscle strength and mobility, cognition, mental health, and quality of life in patients with IHD.

Objective 1- To evaluate the effect of tertiary care hospital-based cardiac rehabilitation on cardiovascular endurance, muscle strength, mobility, cognition, mental health, and overall quality of life in patients with ischemic heart disease (IHD).

 ii. Objective 2- To evaluate the effect of primary health care-based cardiac rehabilitation on the cognitive, cardiovascular endurance, muscle strength and mobility, mental health, and quality of 6 life in patients with IHD.

iii. Objective 3: To compare the effects of CR delivered at PHC and a tertiary care hospital on cognitive, cardiovascular endurance, muscle strength, mobility, mental health, and quality of life in patients with IHD.

 iv. Objective 4: To propose a patient-centric model of care for long-term of CR to optimize functioning in patients with IHD.

Study Design: Experimental study design

METHOD: Plan of Study: Stepwise Methodology: Ethical Approval: Obtain ethical approval from the ethical committee of MGMIHS to ensure compliance with ethical standards. Screening Participants: Identify individuals aged 40–70 diagnosed with Ischemic Heart Disease (IHD), either managed medically or surgically (PTCA/CABG), who have been stable for at least two weeks. Written Consent: Written consent will be obtained from participants who meet the inclusion criteria. Provide an adequate explanation of the study procedure to participants to ensure informed consent. Pre-cardiac rehabilitation (CR) Assessment: Collect baseline scores for participants using the following tools and measures:

Participants:

Inclusion Criteria:

 a. Males and females in the age group 40-70 years

 b. Diagnosed with IHD, managed medically or surgically –PTCA/CABG, stable for at least 2 weeks.

 c. Patients in phase II and phase III cardiac rehabilitation.

 Exclusion Criteria:

a. Any medical red flags

b. Acutely unstable patients with cardiovascular diseases

c. Acute infective pathology

 d. Neurological condition

 e. Non-cooperative patients

f. Unstable psychological condition

g. Who is not willing to participate in the study?

Outcomes:

 1. Duke Activity Status Index

2. Mental Health Quality of Life questionnaire (MHQoL)

3. SF 36 Questionnaire

4. Tampa Kinesiophobia Questionnaire

5. Global Physical Activity Questionnaire

6. Hand grip strength using a dynamometer (in kg)

7. Sit-to-Stand test repetition count

 8. Y balance test distance score

9. 6-Minute Walk Test distance

10. Sit-and-reach test distance for flexibility

11. Blood pressure

 12. Heart rate

13. SpO2 levels

14. Body composition measures (BMI and waist-hip ratio)

Implementation of Cardiac Rehabilitation (CR) Protocol: Conduction of Cardiac Rehabilitation (CR) by international guidelines, AACVPR guidelines for exercise prescription, including the WHO PIR recommendations for IHD. 6. Post-Implementation Assessments: At 6 Weeks: Reassess all participants using the same outcome measures listed above. At 12 Weeks: Measure participants’ scores again using the same tools for consistency.

Intervention and Comparator: Implementation of Cardiac Rehabilitation: Intervention Group A (Control Group): will undergo Tertiary Hospital-Based Cardiac Rehabilitation in outpatient departments. This involves early supervised exercise sessions at tertiary hospitals’ outpatient departments, with multidisciplinary care and patient education. Participants receive conventional Cardiac Rehabilitation (CR) two to five times per week for 12 weeks. Group B (Experimental Group): will undergo Primary Health Care-Based CR Phase III Cardiac Rehabilitation (Long-term maintenance of a Healthy lifestyle Phase) - Community-level sessions conducted at primary care centers with periodic specialist visits. Standardization: Uniformity of exercise regimens across both groups (e.g., duration, intensity, frequency of sessions) will be ensured. All participants will be provided education on lifestyle changes, medication adherence, and dietary modifications. 9. Monitoring and Adherence:

Regular Follow-Ups: Biweekly check-ins will be used to monitor progress and address concerns. Adherence Tracking: Participants will be asked to maintain exercise logs for attendance in hospital or primary care sessions. Participant Support: Counseling or motivation sessions will be provided once a month to improve compliance. 10.

Outcome Assessment all outcome measures will be assessed at Post 6 weeks and 12 weeks of CR.

Data Collection: All the standardized procedures for collecting and recording data will be followed.

Data Analysis: Data will be entered in Microsoft Excel and will be kept ready for further statistical procedures. Follow-up will be maintained for 6 months after the completion of the study.

Ethical Consideration: Ethical approval given by the Ethics Committee for research on human subjects, MGMIHS, 3rd Floor, Sector 9, Kamothe, Navi, Mumbai.

Written consent will be obtained from participants who meet the inclusion criteria. Provide an adequate explanation of the study procedure to participants to ensure informed consent.

 Trial Registration Justification: The Trial will be registered before registering any participants, in compliance with CTRI norms.

 
Close